Sobre IDP Pharma
IDP Pharma is a drug discovery company that develops first-in-class medicines (New Chemical Entities) directed to a novel class of therapeutic targets, intrinsically disordered proteins (IDPs). We are currently focused on exploiting new mechanisms of action to treat cancer diseases. Multiple myeloma is one of our priorities.
Our efforts are directed towards promoting a real shift in cancer therapies to improve the lives of patients. To this end, we have built an extraordinary committed team of experts in the field, supported by a professional advisory board, including IDPs and diseases experts, and business professionals.
Datos IDP Pharma
Fundacion
Spain,
February/2015
Trabajadores
2
Estado
Semilla
Total inversión
1.520.000€
Rondas inversión
-
Early/Startup
05/2016
1.400,00 K€
Inversores IDP Pharma 0
IDP Pharma no tiene a su equipo agregado
Acceleradoras IDP Pharma 0
IDP Pharma no ha pasado por aceleradoras